PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
64 hedge funds and large institutions have $96.3M invested in Pear Therapeutics, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+4
Holders Change %
+6.67%
% of All Funds
1.03%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
13
Increased
24
Reduced
10
Closed
9
Calls
$5K
Puts
$7K
Net Calls
-$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
SM
1
Scoggin Management
New York
|
$586K |
| 2 |
2
BlackRock
New York
|
$4.08M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$1.22M |
| 4 |
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$87.3K |
| 5 |
5
Jane Street
New York
|
$53K |
